Information
-
Patent Application
-
20010031868
-
Publication Number
20010031868
-
Date Filed
May 31, 200123 years ago
-
Date Published
October 18, 200123 years ago
-
CPC
-
US Classifications
-
International Classifications
Abstract
A novel process is described for the preparation of N-(amino-4,6-dihalopyrimidine)formamides of the formula
1
Description
DESCRIPTION
[0001] The invention relates to a novel process for the preparation of N-(amino-4,6-dihalopyrimidine)-formamides of the formula
3
[0002] starting from a 2,5-diamino-4,6-dihalopyrimidine of the general formula
4
[0003] N-(Amino-4,6-dihalopyrimidine) formamides such as N-(2-amino-4,6-dihalopyrimidin-5-yl) formamide are important intermediates for the production of antiviral nucleotide derivatives (EP-A 0 684 236).
[0004] To date, a number of processes for the preparation of N-(2-amino-4,6-dihalopyrimidin-5-yl) formamide have been disclosed. Thus EP-A 0 684 236, for example, describes a process for the preparation of N-(2-amino-4,6-dihalopyrimidin-5-yl) formamide starting from an aminomalonic ester. In this process, the aminomalonic ester is first cyclized to 2,5-diamino-4,6-dihydroxypyrimidine with guanidine in the presence of an alkoxide and then 4,6-dichloro-N′-(dimethylaminomethylene)pyrimidine-2,5-diamine is formed from this with phosphorus oxychloride in the presence of dimethylformamide. The latter is subsequently converted into the desired product using aqueous propionic acid.
[0005] The disadvantages of this process are, on the one hand, the moderate yield of desired product and, on the other hand, the fact that this process proceeds via 3 stages.
[0006] To date, a number of processes for the preparation of 2,5-diamino-4,6-dihalopyrimidines such as 2,5-diamino-4,6-dichloropyrimidine have also been disclosed. For example, WO 91/01310 describes a process for the preparation of 2,5-diamino-4,6-dichloro-pyrimidine starting from 2,5-diamino-4,6-dihydroxy-pyrimidine in the presence of phosphorus oxychloride and a quaternary ammonium halide or a weakly basic tertiary amine or its salt. In this process, the phosphorus oxychloride serves as a solvent. This process has the disadvantage that it is not reproducible on the industrial scale and the desired final product is only obtained in low yield.
[0007] The object of the present invention was to make available a simpler process for the preparation of N-(amino-4,6-dihalopyrimidine)formamides, in which the desired product is obtained in good yield.
[0008] Surprisingly, it has now been found that if a 2,5-diamino-4,6-dihalopyrimidine of the general formula
5
[0009] in which X is a halogen atom is reacted with formic acid, the final products of the general formula I or II are obtained directly, i.e. without intermediates, in excellent yield.
[0010] Cl or Br can be employed as the halogen atom, preferably Cl is employed. Accordingly, 2,5-diamino-4,6-dichloro- or 2,5-diamino-4,6-dibromopyrimidine is preferably employed as the 2,5-diamino-4,6-dihalopyrimidine.
[0011] The formic acid employed below is at least 70-98% strength formic acid.
[0012] Expediently, if the preparation of the product of the formula I is desired, a 70-80% strength formic acid is employed and the reaction is carried out at a temperature of 20° C. to 60° C., preferably of 25° C. to 55° C.
[0013] If the preparation of the product of the formula II is desired, expediently an 80-98% strength formic acid is employed and the reaction is carried out at a temperature of 0° C. to 30° C., preferably of 10 to 25° C.
[0014] Surprisingly, it has also been found that the starting material 2,5-diamino-4, 6-dihalopyrimidine of the general formula III is obtained in good yield if 2,5-diamino-4,6-dihydroxypyrimidine or its salt of the formula
6
[0015] is reacted with a halogenated hydrocarbon as a solvent in the presence of a phosphorus oxyhalide and a quaternary ammonium halide or an amine.
[0016] 2,5-Diamino-4,6-dihydroxypyrimidine is a commercially available compound. A suitable 2,5-diamino-4,6-dihydroxypyrimidine is also its salts such as its hydrohalide salts such as the hydrochloride salts and hydrobromide salts.
[0017] The phosphorus oxyhalide employed is expediently phosphorus oxychloride or phosphorus oxybromide.
[0018] The amine used can be a primary, secondary or tertiary amine or its salts such as its hydrochloride or hydrobromide salts. The quaternary ammonium halide employed is expediently ammonium chloride or ammonium bromide. Customarily, the amine or the quaternary ammonium halide is employed in an excess based on the 2,5-diamino-4,6-dihydroxypyrimidine, preferably 1 to 10 mol of amine are employed based on 1 mol of 2,5-di-amino-4,6-dihydroxypyrimidine.
[0019] The reaction is expediently carried out at a temperature of 20° C. up to the reflux temperature of the appropriate solvent, preferably of 100 to 120° C.
[0020] The halogenated hydrocarbons used can be halogenated aliphatic hydrocarbons. Examples of halogenated aliphatic hydrocarbons are halogenated alkanes. The halogenated alkane employed can be a halogenated propane such as 1,2,3-trichloropropane.
Example 1
[0021] Preparation of 2,5-diamino-4,6-dichloropyrimidine
[0022] 2,5-Diamino-4,6-dihydroxypyrimidine hydrochloride (0.14 mol, 25 g) was filled into a dry reactor. Dry 1,2,3-trichloropropane (51.96 ml) was then added and the whole was stirred. Subsequently, tetra-methylammonium chloride (0.29 mol, 31.25 g) and then POCl3 (0.54-0.81 mol, 124.9-83.28 g, 50.6-75.9 ml) were added. The reaction was heated at reflux temperature (about 115° C.) for 24 h. The reaction was then cooled to below 50° C., ice water (24.44 mol, 440.44 g) was added and the whole was kept below 55° C. Subsequently, the reaction was adjusted to a pH of between 6.5 and 7.0 using 50% strength NaOH (3.12 mol, 124.92 g, 163.3 ml) and the temperature was kept below 55° C. The reaction was stirred at between 50 and 60° C. for 30 min. Tetrahydrofuran (3.7 mol, 267.0 g, 300 ml) was then added. In order to remove undesired material, the whole mixture was filtered through Celite and the filter cake was then washed with ethyl acetate (20.5 mol, 1806.58 g, 2002.86 ml) for subsequent extraction. The organic phase (tetrahydrofuran and ethyl acetate) was washed 3 times with water (5.57 mol, 100.32 g, 100.32 l), dried over NaHCO3 and filtered. Ethyl acetate was removed by vacuum distillation. Hexane (0.77 mol, 66.14 g, 100.36 ml) was then added to the residual organic material, and the whole was cooled to below 10° C., filtered and then dried at 50° C. in vacuo. The title product (0.09 mol, 15.71 g) was obtained as a slightly brownish solid, corresponding to a yield of about 65% based on 2,5-diamino-4,6-dihydroxypyrimidine employed.
Example 2
[0023] Preparation of N-(2-amino-4,6-dichloropyrimidin-5-yl)-formamide
[0024] 2,5-Diamino-4,6-dichloropyrimidine (0.01 mol; 2.0 g) and water (0.25 mol; 4.55 ml) were stirred at room temperature. 98% strength formic acid (0.4 mol; 18.27 g; 14.97 ml) was then added to the reaction. The reaction was subsequently heated to 50-55° C. and kept at this temperature for 3 h. Toluene (0.38 mol; 34.6 g; 40 ml) was then added for the azeotropic distillation under high vacuum at 50° C. (toluene was added twice to guarantee a good distillation, i.e. a total of 80 ml).
[0025] The product was subsequently filtered, washed with water and then dried at 60° C. in vacuo. 0.01 mol (2.0 g) of the abovementioned product was obtained, corresponding to a yield of about 90%.
Example 3
[0026] Preparation of N-(5-amino-4,6-dichloropyrimidin-2-yl)-formamide
[0027] A solution of 2,5-diamino-4,6-dichloro-pyrimidine (0.001 mol; 2.0 g) and 98% strength formic acid (0.5 mol, 22.96 g, 18.8 ml) was stirred overnight at room temperature. Toluene (0.94 mol, 86.76 g, 18.82 ml) was then added and the reaction was cooled to 0-5° C. The product was filtered off and washed with water (1.11 mol, 20.0 g, 20.0 ml). The product was subsequently dried at 50° C. in vacuo. N-(5-Amino-4,6-dichloropyrimidin-2-yl)formamide was detected in the 1H NMR as a single product. 0.01 mol (1.62 g) of the abovementioned product was obtained, corresponding to a yield of about 70%.
Claims
- 1. Process for the preparation of N-(amino-4,6-di-halopyrimidine)formamides of the formula
- 2. Process according to claim 1, characterized in that a 70 to 80% strength formic acid is employed for the preparation of the product of the formula I and the reaction is carried out at a temperature of 20° C. to 60° C.
- 3. Process according to claim 1, characterized in that an 80 to 98% strength formic acid is employed for the preparation of the product of the formula II and the reaction is carried out at a temperature of 0 to 30° C.
- 4. Process according to one of claims 1 to 3, characterized in that the 2,5-diamino-4,6-dihalo-pyrimidine of the general formula
- 5. Process according to claim 4, characterized in that the reaction is carried out at a temperature of 20° C. up to the reflux temperature of the appropriate solvent.
- 6. Process according to one of claims 4 or 5, characterized in that the solvent employed is a halogenated alkane.
- 7. Process for the preparation of a 2,5-diamino-4,6-dihalopyrimidine of the general formula
Priority Claims (3)
Number |
Date |
Country |
Kind |
98124188.8 |
Dec 1998 |
EP |
|
99100788.1 |
Jan 1999 |
EP |
|
99107161.4 |
Apr 1999 |
EP |
|
Provisional Applications (1)
|
Number |
Date |
Country |
|
60146106 |
Jul 1999 |
US |
Divisions (1)
|
Number |
Date |
Country |
Parent |
09461244 |
Dec 1999 |
US |
Child |
09867552 |
May 2001 |
US |